The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
New oral delivery systems for treatment of inflammatory bowel disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Measurement of gastrointestinal pH profiles in normal ambulant human subjects
Evans, D. F., Pye, G., Bramley, R., Clark, A. G., Dyson, T. J., & Hardcastle, J. D. (1988) · Gut · doi:10.1136/gut.29.8.1035 · Cited by 1,240
Polysaccharides in colon-specific drug delivery
Sinha, V. R., & Kumria, R. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00720-7 · Cited by 872
Transit of pharmaceutical dosage forms through the small intestine.
Davis, S. S., Hardy, J. G., & Fara, J. W. (1986) · Gut · doi:10.1136/gut.27.8.886 · Cited by 853
Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon
Salyers, A. A., Vercellotti, J. R., West, S. E., & Wilkins, T. D. (1977) · Applied and Environmental Microbiology · doi:10.1128/aem.33.2.319-322.1977 · Cited by 691
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation
Yang, L., Chu, J. S., & Fix, J. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00004-2 · Cited by 562
Analytical profiles of drug substances and excipients
(1997) · Analytica Chimica Acta · doi:10.1016/s0003-2670(97)89601-8 · Cited by 521
Metabolism of Foreign Compounds by Gastrointestinal Microorganisms
Scheline, R. R. (1973) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06622-0 · Cited by 513
Design of microencapsulated chitosan microspheres for colonic drug delivery
Lorenzo-Lamosa, M. L., Remuñán-López, C., Vila-Jato, J. L., & Alonso, M. J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00203-4 · Cited by 402
Hanauer, S. B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341307 · Cited by 400
The use of polysaccharides to target drugs to the colon
Vandamme, T. (2002) · Carbohydrate Polymers · doi:10.1016/s0144-8617(01)00263-6 · Cited by 378
Microbially triggered drug delivery to the colon
Sinha, V. R., & Kumria, R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00221-x · Cited by 316
Tozaki, H., Komoike, J., Tada, C., Maruyama, T., Terabe, A., Suzuki, T., Yamamoto, A., & Muranishi, S. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js970018g · Cited by 314
Gorbach, S. L. (1971) · Gastroenterology · doi:10.1016/s0016-5085(71)80039-2 · Cited by 306
The human intestinal microflora
Simon, G. L., & Gorbach, S. L. (1986) · Digestive Diseases and Sciences · doi:10.1007/bf01295996 · Cited by 284
Klotz, U. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510040-00001 · Cited by 277
An evaluation of pectin as a carrier for drug targeting to the colon
Ashford, M., Fell, J., Attwood, D., Sharma, H., & Woodhead, P. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90188-b · Cited by 252
Studies of Intestinal Microflora
Gorbach, S. L., Nahas, L., Plaut, A. G., Weinstein, L., Patterson, J. F., & Levitan, R. (1968) · Gastroenterology · doi:10.1016/s0016-5085(68)80072-1 · Cited by 243
An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting
Ashford, M., Fell, J. T., Attwood, D., & Woodhead, P. J. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90344-f · Cited by 239
In Vitro Evaluation of Calcium Pectinate: A Potential Colon-Specific Drug Delivery Carrier
Rubinstein, A., Radai, R., Ezra, M., Pathak, S., & Rokem, J. S. (1993) · Pharmaceutical Research · doi:10.1023/a:1018995029167 · Cited by 235
Very low intraluminal colonic pH in patients with active ulcerative colitis
Fallingborg, J., Christensen, L. A., Jacobsen, B. A., & Rasmussen, S. N. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01297074 · Cited by 226
Studies on pectin formulations for colonic drug delivery
Ashford, M., Fell, J., Attwood, D., Sharma, H., & Woodhead, P. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90028-0 · Cited by 216
Studies on the mechanism of bowel disturbance in ulcerative colitis
Rao, S. S. C., Read, N. W., Brown, C., Bruce, C., & Holdsworth, C. D. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90554-3 · Cited by 215
In vitro evaluation of guar gum as a carrier for colon-specific drug delivery
Prasad, Y. V. R., Krishnaiah, Y. S. R., & Satyanarayana, S. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00181-8 · Cited by 214
Watts, P. J., & Lllum, L. (1997) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049709148695 · Cited by 209
Krishnaiah, Y. S. R., Satyanarayana, V, Dinesh Kumar, B., & Karthikeyan, R. S. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00081-7 · Cited by 191
Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid
Wiwattanapatapee, R., Lomlim, L., & Saramunee, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00461-3 · Cited by 178
Targeting Drugs to the Colon: Delivery Systems for Oral Administration
Ashford, M., & Fell, J. (1994) · Journal of Drug Targeting · doi:10.3109/10611869408996806 · Cited by 178
Milojevic, S., Newton, J. M., Cummings, J. H., Gibson, G. R., Louise Botham, R., Ring, S. G., Stockham, M., & Allwood, M. C. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00112-3 · Cited by 174
Vysloužil, J. (2022) · Praktické lékárenství · doi:10.36290/lek.2022.047 · Cited by 174
Munjeri, O., Collett, J. H., & Fell, J. T. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01607-0 · Cited by 173
Friend, D. R. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90051-d · Cited by 172
Self-citationApproaches and Opportunities in Colon-Specific Drug Delivery
Rubinstein, A. (1995) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v12.i2-3.10 · Cited by 166
Polymeric site-specific pharmacotherapy
(1995) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)90022-5 · Cited by 164
A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development
Gupta, V. K., Beckert, T. E., & Price, J. C. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00649-9 · Cited by 163
Krishnaiah, Y. S. R., Satyanarayana, S., Prasad, Y. V. R., & Rao, S. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00057-1 · Cited by 158
Microbially controlled drug delivery to the colon
Rubinstein, A. (1990) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510110602 · Cited by 158
A polymeric drug for treatment of inflammatory bowel disease
BROWN, J. P., McGarraugh, G. V., Parkinson, T. M., WINGARD, R. E. J., & Onderdonk, A. B. (1983) · Journal of Medicinal Chemistry · doi:10.1021/jm00363a015 · Cited by 150
Colonic Drug Delivery: Prodrug Approach
Sinha, V. R., & Kumria, R. (2001) · Pharmaceutical Research · doi:10.1023/a:1011033121528 · Cited by 149
Pozzi, F., Furlani, P., Gazzaniga, A., Davis, S. S., & Wilding, I. R. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90255-0 · Cited by 148
Yano, H. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00532-6 · Cited by 146
El-Gibaly, I. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00903-6 · Cited by 140
Pectin/chitosan mixtures as coatings for colon-specific drug delivery: an in vitro evaluation
Fernández-Hervás, M. J., & Fell, J. T. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00114-8 · Cited by 134
An in vivo investigation into the suitability of pH dependent polymers for colonic targeting
Ashford, M. B., Fell, J. T., Attwood, D., Sharma, H. L., & Woodhead, P. J. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90406-6 · Cited by 134
Symptoms and stool patterns in patients with ulcerative colitis.
Rao, S. S. C., Holdsworth, C. D., & Read, N. W. (1988) · Gut · doi:10.1136/gut.29.3.342 · Cited by 131
Current Applications of Polysaccharides in Colon Targeting
Hovgaard, L., & BRØNDSTED, H. V. (1996) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v13.i3-4.10 · Cited by 129
Krishnaiah, Y. S. R., Reddy, P. R. B., Satyanarayana, V., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00006-6 · Cited by 127
Macleod, G. S., Fell, J. T., Collett, J. H., Sharma, H. L., & Smith, A.-M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00196-9 · Cited by 126
Drug glycosides: potential prodrugs for colon-specific drug delivery
Friend, D. R., & Chang, G. W. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00379a012 · Cited by 125
Self-citationPolymers for colon specific drug delivery
Schacht, E. H., Gevaert, A., Kenawy, E., Molly, K., Verstraete, W., Adriaensens, P., Carleer, R., & Gelan, J. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00184-0 · Cited by 122
Muraoka, M., Hu, Z., Shimokawa, T., Sekino, S.-I., Kurogoshi, R.-E., Kuboi, Y., Yoshikawa, Y., & Takada, K. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00201-0 · Cited by 121
Development of pectin matrix tablets for colonic delivery of model drug ropivacaine
Ahrabi, S. F., Madsen, G., Dyrstad, K., Sande, S. A., & Graffner, C. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00087-1 · Cited by 120
Use of Azo Polymers for Colon-Specific Drug Delivery
den Mooter, G. V., Maris, B., Samyn, C., Augustijns, P., & Kinget, R. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9702630 · Cited by 119
Phosphated crosslinked guar for colon-specific drug delivery
Gliko-Kabir, I., Yagen, B., Baluom, M., & Rubinstein, A. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00180-7 · Cited by 116
Chondroitin sulfate: A potential biodegradable carrier for colon-specific drug delivery
Rubinstein, A., Nakar, D., & Sintov, A. C. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90054-6 · Cited by 115
Crosslinked dextran — a new capsule material for colon targeting of drugs
BRØNDSTED, H. V., Andersen, C. K., & Hovgaard, L. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00233-2 · Cited by 114
Aiedeh, K., & Taha, M. O. (1999) · Archiv der Pharmazie · doi:10.1002/(sici)1521-4184(19993)332:3<103::aid-ardp103>3.0.co;2-u · Cited by 114
Wong, D., Larrabee, S., Clifford, K., Tremblay, J., & Friend, D. R. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)01633-7 · Cited by 110
Self-citationOral colon-specific drug delivery
Pavelić, Ž., Nigović, B., Konosić, P., & Bećirević‐Laćan, M. (2006) · Cited by 110
Sasaki, Y., Hada, R., Nakajima, H., Fukuda, S., & Munakata, A. (1997) · PubMed · Cited by 107
Pectin/Ethylcellulose Film Coating Formulations for Colonic Drug Delivery
Wakerly, Z., Fell, J. T., Attwood, D., et al. (1996) · Pharmaceutical Research · doi:10.1023/a:1016016404404 · Cited by 103
Design of novel bioconjugates for targeted drug delivery
Lu, Z., Shiah, J.-G., Sakuma, S., Kopečková, P., & Kopec̆ek, J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00495-3 · Cited by 103
McLeod, A. D., Friend, D. R., & Tozer, T. N. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830919 · Cited by 103
Self-citationSemdé, R., Amighi, K., Devleeschouwer, M. J., & Moes, A. J. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00467-6 · Cited by 100
Krishnaiah, Y. S. R., Satyanarayana, V., Kumar, B., Rs, K., & Bhaskar, P. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00139-8 · Cited by 100
Katori, N., Aoyagi, N., & Terao, T. (1995) · Pharmaceutical Research · doi:10.1023/a:1016231010301 · Cited by 98
THE FAECAL FLORA IN ULCERATIVE COLITIS
Hoogkamp-Korstanje, J. A. A., & Kc, W. (1975) · Journal of Medical Microbiology · doi:10.1099/00222615-8-4-491 · Cited by 96
Krishnaiah, Y. S. R., Satyanarayana, S., & Prasad, Y. V. R. (1999) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100102221 · Cited by 95
Fate of β-Cyclodextrin in the Human Intestine
Flourié, B., Molis, C., Achour, L., Dupas, H., Hatat, C., & Rambaud, J. C. (1993) · Journal of Nutrition · doi:10.1093/jn/123.4.676 · Cited by 95
Colon-Specific Drug Delivery Systems
Sarasija, S., & Hota, A. (2000) · Indian Journal of Pharmaceutical Sciences · Cited by 92
Chiu, H.-C., Hsiue, G.-H., Lee, Y.-P., & Huang, L.-W. (1999) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856299x00504 · Cited by 88
MCLEOD, A., FRIEND, D., & Tozer, T. N. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90269-l · Cited by 88
Self-citationCharacterization of plant polysaccharide- and mucin-fermenting anaerobic bacteria from human feces
Bayliss, C. E., & Houston, A. P. (1984) · Applied and Environmental Microbiology · doi:10.1128/aem.48.3.626-632.1984 · Cited by 86
Milojevic, S., NEWTON, J. M., Cummings, J. H., et al. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00113-1 · Cited by 85
Gupta, V. K., Assmus, M., Beckert, T. E., et al. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00650-5 · Cited by 85
Targeting in the gastrointestinal tract: new approaches.
Ritschel, W. A. (1991) · PubMed · Cited by 84
Anaerobic gram-negative faecal flora in patients with Crohn's Disease and healthy subjects
Embden, J. G. H. R.-V., & Both-Patoir, H. C. (1983) · Antonie van Leeuwenhoek · doi:10.1007/bf00393670 · Cited by 83
BOTH, H., Torp-Pedersen, K., Kreiner, S., Hendriksen, C., & Binder, V. (1983) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528309182127 · Cited by 83
Novel oral colon-specific drug delivery systems for pharmacotherapy of peptides and nonpeptide drugs
Reddy, S. (1999) · Drugs of today · doi:10.1358/dot.1999.35.7.548266 · Cited by 82
Takaya, T., Ikeda, C., Imagawa, N., Niwa, K., & Takada, K. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb05834.x · Cited by 82
Biorecognizable HPMA copolymer–drug conjugates for colon-specific delivery of 9-aminocamptothecin
Sakuma, S., Lu, Z., Kopečková, P., & Kopec̆ek, J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00405-9 · Cited by 80
Shameem, M., Katori, N., Aoyagi, N., & Kojima, S. (1995) · Pharmaceutical Research · doi:10.1023/a:1016270701021 · Cited by 79
Semdé, R., Amighi, K., Devleeschouwer, M. J., & Moes, A. J. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00465-2 · Cited by 77
Enzymic degradation of .alpha.- and .beta.-cyclodextrins by Bacteroides of the human colon
Antenucci, R. N., & Palmer, J. K. (1984) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00126a025 · Cited by 76
Friend (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00348.x · Cited by 75
Simonsen, L., Hovgaard, L., Mortensen, P. B., & Brøndsted, H. (1995) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(95)00023-6 · Cited by 75
Calcium Alginate Beads as Core Carriers of 5-Aminosalicylic Acid
Lin, S. Y., & Ayres, J. W. (1992) · Pharmaceutical Research · doi:10.1023/a:1015887318767 · Cited by 75
DEGRADATION OF DEXTRANS BY ENZYMES OF INTESTINAL BACTERIA
Sery, T. W., & Hehre, E. J. (1956) · Journal of Bacteriology · doi:10.1128/jb.71.3.373-380.1956 · Cited by 75
Gastrointestinal Drug Absorption: Is It Time to Consider Heterogeneity as Well as Homogeneity?
Macheras, P. E., & Argyrakis, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012183313218 · Cited by 74
Optimum dose of olsalazine for maintaining remission in ulcerative colitis.
Travis, S. P. L., Tysk, C., de Silva, H. J., Sandberg–Gertzén, H., Jewell, D. P., & Järnerot, G. (1994) · Gut · doi:10.1136/gut.35.9.1282 · Cited by 74
In vitro degradation by colonic bacteria of inulinHP incorporated in eudragit RS films
Vervoort, L., & Kinget, R. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04322-5 · Cited by 74
Siew, L. F., Basit, A. W., & Newton, J. M. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00098-1 · Cited by 72
Cummings, J. H., Milojevic, S., Harding, M., Coward, W. A., Gibson, G. R., Botham, R. L., Ring, S. G., Wraight, E. P., Stockham, M. A., Allwood, M. C., et al. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00186-7 · Cited by 70
Targeting of drugs and vaccines to the gut
Wilding, I. R., Davis, S. S., & O’Hagan, D. T. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90006-x · Cited by 69
Evaluation of an intestinal pressure-controlled colon delivery capsules prepared by a dipping method
Jeong, Y., Ohno, T., Hu, Z., Yoshikawa, Y., Shibata, N., Nagata, S., & Takada, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00211-5 · Cited by 69
Studies on lactulose formulations for colon-specific drug delivery
Katsuma, M., Watanabe, S., Kawai, H., Takemura, S., Masuda, Y., & Fukui, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00429-5 · Cited by 66
Studies on Amidated Pectins as Potential Carriers in Colonic Drug Delivery
Wakerly, Z., Fell, J. T., Attwood, D., & Parkins, D. A. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06856.x · Cited by 65
Adkin, D. A., Kenyon, C. J., Lerner, E., Landau, I., Strauss, E., Caron, D., Penhasi, A., Rubinstein, A., & Wilding, I. R. (1997) · Pharmaceutical Research · doi:10.1023/a:1012019820603 · Cited by 63
Digenis, G. A., & Sandefer, E. P. (1991) · PubMed · Cited by 60
Siew, L. F., Basit, A. W., & Newton, J. M. (2000) · AAPS PharmSciTech · doi:10.1208/pt010322 · Cited by 58
Leaching of pectin from mixed pectin/insoluble polymer films intended for colonic drug delivery
Semdé, R., Amighi, K., Pierre, D., Devleeschouwer, M. J., & Moes, A. J. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00269-5 · Cited by 58
A budesonide prodrug accelerates treatment of colitis in rats.
Cui, N., Friend, D. R., & Fedorak, R. N. (1994) · Gut · doi:10.1136/gut.35.10.1439 · Cited by 58
Self-citationThe degradation of guar gum by a faecal incubation system
Tomlin, J., Read, N. W., Edwards, C. A., & Duerden, B. I. (1986) · British Journal Of Nutrition · doi:10.1079/bjn19860055 · Cited by 57
Tozaki, H., Fujita, T., Odoriba, T., Terabe, A., Suzuki, T., Tanaka, C., Okabe, S., Muranishi, S., & Yamamoto, A. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00044-2 · Cited by 55
Inulin hydrogels. II. In vitro degradation study
Vervoort, L., Rombaut, P., den Mooter, G. V., et al. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00201-4 · Cited by 54
Macleod, G. S., Fell, J. T., & Collett, J. H. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00197-0 · Cited by 51
McDougall, C. J., Wong, R., Scudera, P., Lesser, M., & DeCosse, J. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316512 · Cited by 48
Krishnaiah, Y. S. R., Satyanarayana, V., Kumar, B., & Karthikeyan, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290022697 · Cited by 48
DEXTRAN-SPLITTING ANAEROBIC BACTERIA FROM THE HUMAN INTESTINE
Hehre, E. J., & Sery, T. W. (1952) · Journal of Bacteriology · doi:10.1128/jb.63.3.424-426.1952 · Cited by 46
Cooke, E. M. (1967) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700940225 · Cited by 45
Yang, L., Watanabe, S., Li, J., Chu, J. S., Katsuma, M., Yokohama, S., & Fix, J. A. (2003) · Pharmaceutical Research · doi:10.1023/a:1022660305931 · Cited by 42
The splitting of dextran and isomaltose by animal tissues
Rosenfeld, E. L., & Lukomskaia, I. S. (1957) · Clinica Chimica Acta · doi:10.1016/0009-8981(57)90090-6 · Cited by 42
Faecal stasis in proctocolitis
Lennard‐Jones, J. E., Langman, M. J. S., & Jones, F. A. (1962) · Gut · doi:10.1136/gut.3.4.301 · Cited by 42
Colonic delivery of dexamethasone: a pharmacoscintigraphic evaluation
KENYON, C. J., Nardi, R. V., WONG, D., Hooper, G., Wilding, I. R., & Friend, D. R. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.93265000.x · Cited by 41
Self-citationHu, Z., Kimura, G., Mawatari, S.-S., Shimokawa, T., Yoshikawa, Y., & Takada, K. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00090-x · Cited by 40
Fedorak, R. N., Haeberlin, B., Empey, L. R., Cui, N., Nolen, H. W., Jewell, L. D., & Friend, D. R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90130-2 · Cited by 37
Self-citationRubinstein, A., & Kabir, I. (1995) · Stp Pharma Sciences · Cited by 36
Gibson, G. R., Macfarlane, S., & Cummings, J. H. (1990) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.1990.tb00174.x · Cited by 34
Davis, S. S., Robertson, C. S., & Wilding, I. R. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90142-b · Cited by 31
Azopolymers: a means of colon specific drug delivery?
Lloyd, A. W., Martin, G. P., & Soozandehfar, S. H. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90011-6 · Cited by 30
Ueda, S., Ibuki, R., Kawamura, A., Murata, S., Takahashi, T., Kimura, S., & Hata, T. (1994) · Journal of drug targeting · doi:10.3109/10611869409015901 · Cited by 30
Increased Faecal Glycosidases in Patients with Crohn’s Disease
Embden, J. G. H. R.-V., & Lieshout, L. M. C. V. (2009) · Digestion · doi:10.1159/000199486 · Cited by 29
Takaya, T., Sawada, K., Suzuki, H., Funaoka, A., Matsuda, K., & Takada, K. (1997) · Journal of drug targeting · doi:10.3109/10611869708995842 · Cited by 24
NAKAMURA, J., Tagami, C., NISHIDA, K., & SASAKI, H. (1992) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.40.547 · Cited by 17
Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease
Yamani, J. E., Mizon, C., Capon, C., Colombel, J., Fournet, B., Cortot, A., & Mizon, J. (1992) · Clinical Science · doi:10.1042/cs0830409 · Cited by 17
[Decrease of fecal beta-galactosidase activity in Crohn disease].
Canva-Delcambre, V., Soenen, V., Mizon, C., Cortot, A., Mizon, J., & Colombel, J. (1993) · PubMed · Cited by 8
Cited by
Targeted Drug Delivery to Intestinal Macrophages by Bioactive Nanovesicles Released from Grapefruit
Wang, B., Zhuang, X., Deng, Z.-B., Jiang, H., Mu, J., Wang, Q., Xiang, X., Guo, H., Zhang, L., Dryden, G., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2013.190 · Cited by 634
Drug delivery to inflamed colon by nanoparticles: Comparison of different strategies
Coco, R., Plapied, L., Pourcelle, V., Jérôme, C., Brayden, D. J., Schneider, Y.-J., & Préat, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.017 · Cited by 162
Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease
Xiao, B., & Merlin, D. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.730517 · Cited by 145
An intestinal Trojan horse for gene delivery
Peng, H., Wang, C., Xu, X., Yu, C., & Wang, Q. (2015) · Nanoscale · doi:10.1039/c4nr06377e · Cited by 66
Film coatings for oral pulsatile release
Maroni, A., Zema, L., Loreti, G., Palugan, L., & Gazzaniga, A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.010 · Cited by 55
Metadata
- Authors
- Friend, D. R.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 57
- Issue
- 2
- Pages
- 247-265
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1976467447
- Cited by
- 306
- References
- 127
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.